by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Ketacyn Pharmaceuticals / www.ketacynpharma.com Warning Letter Details

Warning Letter

Ketacyn Pharmaceuticals / www.ketacynpharma.com

Ketacyn Pharmaceuticals / www.ketacynpharma.com, United States

Issue DateJune 23, 2026

FEI NumberN/A

Violations3

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Unapproved New Drugs/Misbranded

Ketacyn Pharmaceuticals / www.ketacynpharma.com FDA Warning Letter, June 23, 2026